{"id":1655,"date":"2021-08-10T13:29:45","date_gmt":"2021-08-10T13:29:45","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmjopen\/?p=1655"},"modified":"2021-08-10T13:35:08","modified_gmt":"2021-08-10T13:35:08","slug":"top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/","title":{"rendered":"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency"},"content":{"rendered":"<figure id=\"attachment_1656\" aria-describedby=\"caption-attachment-1656\" style=\"width: 300px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1656 size-medium\" title=\"Image credit: &quot;Pharmaceuticals&quot; by Nuevo Anden is licensed under CC BY-NC 2.0\" src=\"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb-300x199.jpg\" alt=\"\" width=\"300\" height=\"199\" srcset=\"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb-300x199.jpg 300w, https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb.jpg 500w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><figcaption id=\"caption-attachment-1656\" class=\"wp-caption-text\">Image credit: &#8220;Pharmaceuticals&#8221; by Nuevo Anden is licensed under CC BY-NC 2.0<\/figcaption><\/figure>\n<p><span style=\"font-weight: 400\"><br \/>\nCOVID-19 remains dominant in our top ten most read papers for July, 2021, with six of the ten spots held by COVID-19-related papers and Li <\/span><i><span style=\"font-weight: 400\">et al<\/span><\/i><span style=\"font-weight: 400\">.\u2019s <a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/2\/e045524\">protocol<\/a> for a systematic review and meta-analysis on the impact of COVID-19 on female fertility reclaiming the top spot. But the two new entries in the top ten focus on other topics.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">Averbuch <\/span><i><span style=\"font-weight: 400\">et al<\/span><\/i><span style=\"font-weight: 400\">.\u2019s <a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/7\/e043256\">systematic review<\/a> on academic bullying in medical settings entered the most read chart at number 6. As detailed <a href=\"https:\/\/blogs.bmj.com\/bmjopen\/2021\/07\/13\/men-appear-to-bully-more-commonly-than-women-in-academic-medicine\/\">previously<\/a><\/span><span style=\"font-weight: 400\">, the researchers from McMaster University (ON, Canada) analysed findings from 68 studies from various countries published between 1999 and 2021, representing data from 82\u2009349 respondents (consultants and trainees). They found that the most commonly reported pattern of bullying was overwork as a form of punishing behaviour and the most common impact was psychological distress. Perpetrators were most often consultants, and men were identified as the most common perpetrators, while women were the most common victims. Notably, less than a third of victims reported the bullying. Poor enforcement of anti-bullying policies, hierarchical power structures, and normalisation of bullying were identified as facilitators of bullying behaviours in academic medical settings. In commenting on the study to <\/span><i><span style=\"font-weight: 400\">Medscape Medical News<\/span><\/i><span style=\"font-weight: 400\">, lead investigator Harriette Van Spall <a href=\"https:\/\/www.medscape.com\/viewarticle\/954709\">explained<\/a> how the research was inspired by her own personal experience. \u201cSome behaviours were excruciating to deal with, protesting against them would bring more on, and every day was filled with dread. It took sheer will to show up at work to care for patients, to complete research I was leading, and to have hope and my academic output, income, and personal well-being dropped during those years.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">Also new in the top ten, Axson <\/span><i><span style=\"font-weight: 400\">et al<\/span><\/i><span style=\"font-weight: 400\">.\u2019s <a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/7\/e053248\">article<\/a> on clinical trial transparency and data sharing among biopharmaceutical companies entered the chart at number 9. The study, which follows on from earlier work from the same group, used the established Good Pharma Scorecard (GPS) transparency measures to appraise novel drugs and biologics that received approval from the US Food and Drug Administration (FDA) in 2016\u201317 and their company sponsors. The researchers found that there was no apparent difference in transparency between US-based and non-US companies and no difference between the transparency of reporting for biologics and non-biologic drugs. However, large companies (those in the top 20 largest companies by market capitalisation) were found to be significantly more transparent than smaller companies, with generally better data sharing procedures and superior implementation of FDA Amendments Act trial reporting requirements.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Here is the full list of most read papers in <\/span><i><span style=\"font-weight: 400\">BMJ Open<\/span><\/i><span style=\"font-weight: 400\"> during July, 2021:<\/span><\/p>\n<table style=\"border-collapse: collapse\" border=\"1\" cellspacing=\"5\" cellpadding=\"5\">\n<caption>*<i>Most read figures are based on pdf downloads and full text views. Abstract views are excluded.<\/i><\/caption>\n<tbody>\n<tr>\n<td><b>Rank* <\/b><\/td>\n<td><b>Author(s) <\/b><\/td>\n<td><b>Title<\/b><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td>Li <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/2\/e045524\">Impact of COVID-19 on female fertility: a systematic review and meta-analysis protocol<\/a><\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Houben <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/10\/9\/e037837\">Cohort profile: the PHARMO Perinatal Research Network (PPRN) in the Netherlands: a population-based mother\u2013child linked cohort<\/a><\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Gadermann<i> et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/1\/e042871\">Examining the impacts of the COVID-19 pandemic on family mental health in Canada: findings from a national cross-sectional study<\/a><\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Espiritu <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/10\/11\/e040944\">The Philippine <em>C<\/em>OVID-19 <em>O<\/em>utcomes: a <em>R<\/em>etrospective study <em>O<\/em>f <em>N<\/em>eurological manifestations and <em>A<\/em>ssociated symptoms (The Philippine <em>CORONA<\/em> study): a protocol study<\/a><\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Dahlen <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/6\/e047040\">Intrapartum interventions and outcomes for women and children following induction of labour at term in uncomplicated pregnancies: a 16-year population-based linked data study<\/a><\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Averbuch <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/7\/e043256\">Systematic review of academic bullying in medical settings: dynamics and consequences<\/a><\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Dennis <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/3\/e048391\">Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study<\/a><\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Dost <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/10\/11\/e042378\">Perceptions of medical students towards online teaching during the COVID-19 pandemic: a national cross-sectional survey of 2721 UK medical students<\/a><\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Axson <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/7\/e053248\">Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis<\/a><\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>McAloon <i>et al<\/i>.<\/td>\n<td><a href=\"https:\/\/bmjopen.bmj.com\/content\/10\/8\/e039652\">Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>COVID-19 remains dominant in our top ten most read papers for July, 2021, with six of the ten spots held by COVID-19-related papers and Li et al.\u2019s protocol for a systematic review and meta-analysis on the impact of COVID-19 on female fertility reclaiming the top spot. But the two new entries in the top ten [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":458,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2470,2471,511],"tags":[],"class_list":["post-1655","post","type-post","status-publish","format-standard","hentry","category-content","category-highly-accessed","category-in-the-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency - BMJ Open<\/title>\n<meta name=\"description\" content=\"COVID-19 remains dominant in our top ten most read papers for July, 2021, with six of the ten spots held by COVID-19-related papers and Li et al.\u2019s protocol for a systematic review and meta-analysis on the impact of COVID-19 on female fertility reclaiming the top spot. But the two new entries in the top ten focus on other topics.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency - BMJ Open\" \/>\n<meta property=\"og:description\" content=\"COVID-19 remains dominant in our top ten most read papers for July, 2021, with six of the ten spots held by COVID-19-related papers and Li et al.\u2019s protocol for a systematic review and meta-analysis on the impact of COVID-19 on female fertility reclaiming the top spot. But the two new entries in the top ten focus on other topics.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/\" \/>\n<meta property=\"og:site_name\" content=\"BMJ Open\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-10T13:29:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-10T13:35:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb-300x199.jpg\" \/>\n<meta name=\"author\" content=\"nbennet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"nbennet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/\"},\"author\":{\"name\":\"nbennet\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#\\\/schema\\\/person\\\/e84a1d83f2087204cfd1225b93484f90\"},\"headline\":\"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency\",\"datePublished\":\"2021-08-10T13:29:45+00:00\",\"dateModified\":\"2021-08-10T13:35:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/\"},\"wordCount\":668,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2021\\\/08\\\/1488488588_892e45dbdb-300x199.jpg\",\"articleSection\":[\"Content\",\"Highly accessed\",\"In the news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/\",\"name\":\"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency - BMJ Open\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2021\\\/08\\\/1488488588_892e45dbdb-300x199.jpg\",\"datePublished\":\"2021-08-10T13:29:45+00:00\",\"dateModified\":\"2021-08-10T13:35:08+00:00\",\"description\":\"COVID-19 remains dominant in our top ten most read papers for July, 2021, with six of the ten spots held by COVID-19-related papers and Li et al.\u2019s protocol for a systematic review and meta-analysis on the impact of COVID-19 on female fertility reclaiming the top spot. But the two new entries in the top ten focus on other topics.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2021\\\/08\\\/1488488588_892e45dbdb.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2021\\\/08\\\/1488488588_892e45dbdb.jpg\",\"width\":500,\"height\":332},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2021\\\/08\\\/10\\\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/\",\"name\":\"BMJ Open\",\"description\":\"The official blog BMJ Open; a place to discuss medical research and discover the Editor&#039;s monthly top picks.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#organization\",\"name\":\"BMJ Open\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2017\\\/10\\\/blog-logo-bmjopen.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2017\\\/10\\\/blog-logo-bmjopen.png\",\"width\":183,\"height\":34,\"caption\":\"BMJ Open\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#\\\/schema\\\/person\\\/e84a1d83f2087204cfd1225b93484f90\",\"name\":\"nbennet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5e3bca731f22799118fe503f1ea1f7f85daba5a38179779f03f74352dc526991?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5e3bca731f22799118fe503f1ea1f7f85daba5a38179779f03f74352dc526991?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5e3bca731f22799118fe503f1ea1f7f85daba5a38179779f03f74352dc526991?s=96&d=mm&r=g\",\"caption\":\"nbennet\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/author\\\/nbennet\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency - BMJ Open","description":"COVID-19 remains dominant in our top ten most read papers for July, 2021, with six of the ten spots held by COVID-19-related papers and Li et al.\u2019s protocol for a systematic review and meta-analysis on the impact of COVID-19 on female fertility reclaiming the top spot. But the two new entries in the top ten focus on other topics.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/","og_locale":"en_US","og_type":"article","og_title":"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency - BMJ Open","og_description":"COVID-19 remains dominant in our top ten most read papers for July, 2021, with six of the ten spots held by COVID-19-related papers and Li et al.\u2019s protocol for a systematic review and meta-analysis on the impact of COVID-19 on female fertility reclaiming the top spot. But the two new entries in the top ten focus on other topics.\u00a0","og_url":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/","og_site_name":"BMJ Open","article_published_time":"2021-08-10T13:29:45+00:00","article_modified_time":"2021-08-10T13:35:08+00:00","og_image":[{"url":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb-300x199.jpg","type":"","width":"","height":""}],"author":"nbennet","twitter_card":"summary_large_image","twitter_misc":{"Written by":"nbennet","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/"},"author":{"name":"nbennet","@id":"https:\/\/blogs.bmj.com\/bmjopen\/#\/schema\/person\/e84a1d83f2087204cfd1225b93484f90"},"headline":"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency","datePublished":"2021-08-10T13:29:45+00:00","dateModified":"2021-08-10T13:35:08+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/"},"wordCount":668,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb-300x199.jpg","articleSection":["Content","Highly accessed","In the news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/","url":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/","name":"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency - BMJ Open","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb-300x199.jpg","datePublished":"2021-08-10T13:29:45+00:00","dateModified":"2021-08-10T13:35:08+00:00","description":"COVID-19 remains dominant in our top ten most read papers for July, 2021, with six of the ten spots held by COVID-19-related papers and Li et al.\u2019s protocol for a systematic review and meta-analysis on the impact of COVID-19 on female fertility reclaiming the top spot. But the two new entries in the top ten focus on other topics.\u00a0","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2021\/08\/1488488588_892e45dbdb.jpg","width":500,"height":332},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmjopen\/2021\/08\/10\/top-10-most-read-in-july-bullying-in-academic-medicine-and-clinical-trial-transparency\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmjopen\/"},{"@type":"ListItem","position":2,"name":"Top 10 Most Read in July: bullying in academic medicine and clinical trial transparency"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmjopen\/#website","url":"https:\/\/blogs.bmj.com\/bmjopen\/","name":"BMJ Open","description":"The official blog BMJ Open; a place to discuss medical research and discover the Editor&#039;s monthly top picks.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmjopen\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmjopen\/#organization","name":"BMJ Open","url":"https:\/\/blogs.bmj.com\/bmjopen\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmjopen\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/10\/blog-logo-bmjopen.png","contentUrl":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/10\/blog-logo-bmjopen.png","width":183,"height":34,"caption":"BMJ Open"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmjopen\/#\/schema\/person\/e84a1d83f2087204cfd1225b93484f90","name":"nbennet","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5e3bca731f22799118fe503f1ea1f7f85daba5a38179779f03f74352dc526991?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5e3bca731f22799118fe503f1ea1f7f85daba5a38179779f03f74352dc526991?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5e3bca731f22799118fe503f1ea1f7f85daba5a38179779f03f74352dc526991?s=96&d=mm&r=g","caption":"nbennet"},"url":"https:\/\/blogs.bmj.com\/bmjopen\/author\/nbennet\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/posts\/1655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/users\/458"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/comments?post=1655"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/posts\/1655\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/media?parent=1655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/categories?post=1655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/tags?post=1655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}